Difference between revisions of "Alpha-methylacyl-CoA racemase"

Jump to navigation Jump to search
Line 9: Line 9:
==Positive or negative==
==Positive or negative==
*[[Nephrogenic adenoma]].
*[[Nephrogenic adenoma]].
*[[Urothelial carcinoma]] - not useful for differentating ''prostate'' versus ''bladder''.
*[[Urothelial carcinoma]] - not useful for prostate versus bladder; it is positive in ~50% of [[UCC]].<ref name=pmid16315020>{{Cite journal  | last1 = Langner | first1 = C. | last2 = Rupar | first2 = G. | last3 = Leibl | first3 = S. | last4 = Hutterer | first4 = G. | last5 = Chromecki | first5 = T. | last6 = Hoefler | first6 = G. | last7 = Rehak | first7 = P. | last8 = Zigeuner | first8 = R. | title = Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression. | journal = Virchows Arch | volume = 448 | issue = 3 | pages = 325-30 | month = Mar | year = 2006 | doi = 10.1007/s00428-005-0129-6 | PMID = 16315020 }}</ref>


==Negative==
==Negative==
48,830

edits

Navigation menu